The Ampicillin and Sulbactam product will be sold in 1.5g and 3g single-dose and 15g pharmacy bulk package vials.
However, Ampicillin product will be sold in five presentations: 250 mg, 500 mg, 1g, and 2g single-dose vials and 10g pharmacy bulk package vials.
Sagent Pharma founder, chairman of the board and CEO said that the launch of these products increases Sagent’s anti-infectives portfolio to eleven injectable products in a variety of sizes, concentrations and packaging configurations.
“As we continue to expand our product offering, we are able to provide customers with a growing array of anti-infectives, each featuring our proprietary PreventIV Measures labeling and packaging,” Yordon said.